William J. Federici, Director at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 40 shares at $1.01 ($40) on 2022-06-14, disclosed to the SEC on 2022-06-16.
Open-market sale of $40 ZYNE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| WST | SELL | 2018-06-11 | $8.2M | — | Filing → |
| WST | SELL | 2018-05-11 | $4.5M | — | Filing → |
| WST | SELL | 2017-12-12 | $2.1M | — | Filing → |